These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35312046)

  • 1. Electroencephalogram aperiodic power spectral slope can be reliably measured and predicts ADHD risk in early development.
    Karalunas SL; Ostlund BD; Alperin BR; Figuracion M; Gustafsson HC; Deming EM; Foti D; Antovich D; Dude J; Nigg J; Sullivan E
    Dev Psychobiol; 2022 Apr; 64(3):e22228. PubMed ID: 35312046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EEG power spectral slope differs by ADHD status and stimulant medication exposure in early childhood.
    Robertson MM; Furlong S; Voytek B; Donoghue T; Boettiger CA; Sheridan MA
    J Neurophysiol; 2019 Dec; 122(6):2427-2437. PubMed ID: 31619109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aperiodic and periodic components of oscillatory brain activity in relation to cognition and symptoms in pediatric ADHD.
    Dakwar-Kawar O; Mentch-Lifshits T; Hochman S; Mairon N; Cohen R; Balasubramani P; Mishra J; Jordan J; Cohen Kadosh R; Berger I; Nahum M
    Cereb Cortex; 2024 Jun; 34(6):. PubMed ID: 38858839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and cognitive correlates of the aperiodic (1/f-like) exponent of the EEG power spectrum in adolescents with and without ADHD.
    Ostlund BD; Alperin BR; Drew T; Karalunas SL
    Dev Cogn Neurosci; 2021 Apr; 48():100931. PubMed ID: 33535138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of dynamic neural oscillatory response to environmental conditions marks childhood attention deficit hyperactivity disorder.
    Arnett AB; Fearey M; Peisch V; Levin AR
    J Child Psychol Psychiatry; 2022 Dec; 63(12):1615-1621. PubMed ID: 35620850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of d-Methylphenidate, Guanfacine, and Their Combination on Electroencephalogram Resting State Spectral Power in Attention-Deficit/Hyperactivity Disorder.
    Loo SK; Bilder RM; Cho AL; Sturm A; Cowen J; Walshaw P; Levitt J; Del'Homme M; Piacentini J; McGough JJ; McCracken JT
    J Am Acad Child Adolesc Psychiatry; 2016 Aug; 55(8):674-682.e1. PubMed ID: 27453081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of aperiodic spectral slope in event-related potentials and cognition among children with and without attention deficit hyperactivity disorder.
    Arnett AB; Peisch V; Levin AR
    J Neurophysiol; 2022 Dec; 128(6):1546-1554. PubMed ID: 36382902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infant excitation/inhibition balance interacts with executive attention to predict autistic traits in childhood.
    Carter Leno V; Begum-Ali J; Goodwin A; Mason L; Pasco G; Pickles A; Garg S; Green J; Charman T; Johnson MH; Jones EJH; ;
    Mol Autism; 2022 Dec; 13(1):46. PubMed ID: 36482366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EEG theta and beta power spectra in adolescents with ADHD versus adolescents with ASD + ADHD.
    Bink M; van Boxtel GJ; Popma A; Bongers IL; Denissen AJ; van Nieuwenhuizen Ch
    Eur Child Adolesc Psychiatry; 2015 Aug; 24(8):873-86. PubMed ID: 25374034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aperiodic components and aperiodic-adjusted alpha-band oscillations in children with ADHD.
    Chen R; Liu WJ; Wang JJ; Zhou DD; Wang YF
    J Psychiatr Res; 2024 May; 173():225-231. PubMed ID: 38552332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of stimulant medications on children with attention-deficit/hyperactivity disorder and excessive beta activity in their EEG.
    Clarke AR; Barry RJ; McCarthy R; Selikowitz M; Clarke DC; Croft RJ
    Clin Neurophysiol; 2003 Sep; 114(9):1729-37. PubMed ID: 12948803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of medication for attention-deficit/hyperactivity disorder and risk of unintentional injuries in children and adolescents with co-occurring neurodevelopmental disorders.
    Ghirardi L; Chen Q; Chang Z; Kuja-Halkola R; Skoglund C; Quinn PD; D'Onofrio BM; Larsson H
    J Child Psychol Psychiatry; 2020 Feb; 61(2):140-147. PubMed ID: 31625605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate, Guanfacine, and Combined Treatment Effects on Electroencephalography Correlates of Spatial Working Memory in Attention-Deficit/Hyperactivity Disorder.
    Michelini G; Lenartowicz A; Diaz-Fong JP; Bilder RM; McGough JJ; McCracken JT; Loo SK
    J Am Acad Child Adolesc Psychiatry; 2023 Jan; 62(1):37-47. PubMed ID: 35963558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological and Clinical Predictors of Methylphenidate, Guanfacine, and Combined Treatment Outcomes in Children With Attention-Deficit/Hyperactivity Disorder.
    Michelini G; Lenartowicz A; Vera JD; Bilder RM; McGough JJ; McCracken JT; Loo SK
    J Am Acad Child Adolesc Psychiatry; 2023 Apr; 62(4):415-426. PubMed ID: 35963559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication Effects on EEG Biomarkers in Attention-Deficit/Hyperactivity Disorder.
    Isiten HN; Cebi M; Sutcubasi Kaya B; Metin B; Tarhan N
    Clin EEG Neurosci; 2017 Jul; 48(4):246-250. PubMed ID: 27798290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of stimulant medications on the EEG of children with Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive type.
    Clarke AR; Barry RJ; McCarthy R; Selikowitz M; Brown CR; Croft RJ
    Int J Psychophysiol; 2003 Feb; 47(2):129-37. PubMed ID: 12568943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α2-Adrenergic Agonists or Stimulants for Preschool-Age Children With Attention-Deficit/Hyperactivity Disorder.
    Harstad E; Shults J; Barbaresi W; Bax A; Cacia J; Deavenport-Saman A; Friedman S; LaRosa A; Loe IM; Mittal S; Tulio S; Vanderbilt D; Blum NJ
    JAMA; 2021 May; 325(20):2067-2075. PubMed ID: 33946100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention deficit disorder, stimulant use, and childhood body mass index trajectory.
    Schwartz BS; Bailey-Davis L; Bandeen-Roche K; Pollak J; Hirsch AG; Nau C; Liu AY; Glass TA
    Pediatrics; 2014 Apr; 133(4):668-76. PubMed ID: 24639278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study.
    Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ
    J Dev Behav Pediatr; 2014 Sep; 35(7):448-57. PubMed ID: 25180895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.